Search results for "emostasi"

showing 10 items of 138 documents

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct

Interleukin 12 induces activation of fibrinolysis and coagulation in humans

2001

Interleukin 12 (IL-12) has potential efficacy in malignant, infectious and allergic diseases. Its side-effects include activation of coagulation and fibrinolysis, as documented in chimpanzees. We assessed the coagulative and fibrinolytic response in 18 patients with renal cell carcinoma after subcutaneous injection of 0.5 microg/kg recombinant human IL-12. IL-12 induced a fibrinolytic response in 17 patients (94%): plasmin-alpha2-anti-plasmin complexes (PAPc) increased from 11.8 +/- 6.6 nmol/l (mean +/- SD) to a maximum of 18.8 +/- 7.4 nmol/l at 72 h. Baseline levels of tissue plasminogen activator (tPA) and plasminogen-activator inhibitor-I (PAI) were elevated in eight and 14 patients resp…

medicine.medical_specialtyNecrosisbusiness.industrymedicine.medical_treatmentHematologyTissue plasminogen activatorSubcutaneous injectionEndocrinologyCoagulative necrosisCoagulationInternal medicineHemostasisFibrinolysismedicineInterleukin 12medicine.symptombusinessmedicine.drugBritish Journal of Haematology
researchProduct

Extractions without eliminating anticoagulant treatment: A literature review

2010

To establish whether there is a high enough risk of bleeding in patients who take oral anticoagulants, such that it would justify not using oral anticoagulants when performing a dental extraction, as well as if the reason for and anatomical location of the extraction increases such risk. Study We performed a bibliographic search in order to carry out a meta-analytic study using descriptive statistics. We compiled a sample of 1194 patients from the articles selected. Of these patients, a total of 2392 simple, serial surgical extractions were performed; none of the patients interrupted their anticoagulant treatment with warfarin sodium. Of the sample, 83 patients presented a certain degree of…

medicine.medical_specialtyPeriodontal pathologybusiness.industryContraindicationsmedicine.medical_treatmentIncidence (epidemiology)AnticoagulantsDentistrySoft tissue:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurgeryOtorhinolaryngologyDental extractionAnticoagulant therapyMaxillaHemostasisTooth ExtractionUNESCO::CIENCIAS MÉDICASHumansMedicineSurgeryPericoronitisbusinessGeneral DentistryMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Rockall Score Larger Than 7 as a Reliable Criterion for the Selection of Indications for Preventive Transarterial Embolization in a Subgroup of High-…

2017

Background Transarterial embolization (TAE) is an alternative procedure to repeat endoscopy or surgical intervention in the case of re-bleeding after primary endoscopic treatment. The aim of the study was to assess the Rockall score as a criterion for TAE in the case of re-bleeding after endoscopic treatment of non-variceal upper gastrointestinal bleeding (NVUGIB). Methods Out of the 673 patients who underwent emergent endoscopic hemostasis due to NVUGIB, 111 had a high risk of re-bleeding having a Forrest I-IIb ulcer and the Rockall score ≥ 5. From 111 patients, 37 accepted preventive TAE (PE+ group). The control group consisted of 74 patients who underwent standard treatment (PE- group). …

medicine.medical_specialtyPreventive embolizationmedicine.diagnostic_testbusiness.industryStandard treatmentRockall scoremedicine.diseaseEndoscopySurgery03 medical and health sciencesEndoscopic hemostasis0302 clinical medicineTransarterial embolizationmedicineNon-variceal upper gastrointestinal bleeding030211 gastroenterology & hepatologyOriginal Article030212 general & internal medicineUpper gastrointestinal bleedingbusinessRockall scoreRisk assessmentEndoscopic treatmentRisk assessmentGastroenterology Research
researchProduct

Hemostasis in brain tumor surgery using the Aquamantys system

2014

Background: Adequate hemostasis in cranial and spinal tumor surgery is of paramount importance in neurosurgical practice. Generalized ooze bleeding from the surgical walls cavity, coming from neoplastic vessels or nervous tissue, may be problematic. Recent technical advances have dramatically reduced intraoperative complications related to blood loss. Several techniques are usually employed to control hemostasis in tumor surgery, including preoperative embolization, intraoperative hypotension, electrical coagulation, and local application of fibrin sealants or hemostatic matrix, which influence coagulation. Material/Methods: Our aim in this study was to evaluate the efficacy and the safety …

medicine.medical_specialtyRadio WavesBlood Loss SurgicalPreoperative careHemostaticsProduct InvestigationsBlood lossSurgicalPreoperative CaremedicineHumansBrain tumor surgeryHemostasisIntraoperative Caremedicine.diagnostic_testbusiness.industryBrain NeoplasmsSettore MED/27 - Neurochirurgiatumor meningiomaBlood lossMagnetic resonance imagingGeneral MedicineMiddle AgedMagnetic Resonance ImagingSurgeryRadiographyNasal MucosaCoagulationSpinal tumorHemostasisTumor surgeryFemalebusinessMeningiomaFollow-Up Studies
researchProduct

Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients

2021

Background: Hemostatic abnormalities have been described in COVID-19, and pulmonary microthrombosis was consistently found at autopsy with concomitant severe lung damage. Methods: This is a retrospective observational cross-sectional study including consecutive patients with COVID-19 pneumonia who underwent unenhanced chest CT upon admittance at the emergency room (ER) in one large academic hospital. QCT was used for the calculation of compromised lung volume (%CL). Clinical data were retrieved from patients’ files. Laboratory data were obtained upon presentation at the ER. Aim: The aim of this study was to evaluate the correlation between hemostatic abnormalities and lung involvement in pa…

medicine.medical_specialtySARS-CoV-2 pneumonia610 Medicine & health2700 General Medicine030204 cardiovascular system & hematologyLung injuryGastroenterologyArticlelung volume measurements03 medical and health sciences0302 clinical medicineInternal medicineD-dimerMedicineLung volumesCOVIDLungbusiness.industry10031 Clinic for AngiologyRCOVID-19General MedicineOdds ratiomedicine.diseasePneumoniamedicine.anatomical_structure030220 oncology & carcinogenesisHemostasisConcomitantD-dimerhemostasisMedicinebusiness
researchProduct

Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions.

2009

Abstract Abstract 1290 Poster Board I-312 Background Excessive bleeding represents a major complication of surgical interventions, and its control is especially relevant in patients with Congenital Bleeding Disorders. In FVII deficiency, scanty data is available in surgery to guide treatment strategies. Methods The STER (Seven Treatment Evaluation Registry) is a multi-centre, prospective, observational, web-based registry providing the frame for an extensive and structured data collection. Results As of Dec. 2008, sixty-three surgical operations (36 “major” and 27 “minor”) were performed in 54 subjects (29 females and 25 males) with a FVII deficiency (31 previously symptomatic; 9 with FVIIc…

medicine.medical_specialtybiologyDosebusiness.industrymedicine.medical_treatmentImmunologyCell BiologyHematologymedicine.diseaseBiochemistryThrombosisEffective dose (pharmacology)SurgerySettore MED/15 - Malattie Del SangueDental extractionRecombinant factor VIIaHemostasisOrthopedic surgerymedicinebiology.proteinfactor VIIbusinessGynecological surgery
researchProduct

Outpatient minor oral surgery in patients with hemophilia: A case series of 23 patients

2019

Hemophilia is an inherited coagulation disorder characterized by deficiency of the coagulation factor VIII or IX. When the management of hemostasis is inadequate, these patients are at high risk of experiencing intra and postoperative bleedings after tooth extractions. Coagulation factor replacement therapy allows performing most surgical procedures safely, although the factor levels and length of treatment have not been clearly determined. In this study, we present our experience in a retrospective series of 112 ambulatory tooth extractions under local anesthesia in 23 patients with hemophilia using a coagulation factor replacement therapy in combination with tranexamic acid. The results o…

medicine.medical_specialtybusiness.industryOral surgeryCase Report030206 dentistry030204 cardiovascular system & hematology:CIENCIAS MÉDICAS [UNESCO]Surgery03 medical and health sciences0302 clinical medicineCoagulationHemostasisUNESCO::CIENCIAS MÉDICASAmbulatoryMedicineLocal anesthesiaIn patientOral SurgerybusinessGeneral DentistryCoagulation DisorderTranexamic acidmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Platelet Cut-Off For Anticoagulant Therapy In Cancer Patients With Venous Thromboembolism and Thrombocytopenia: An Expert Opinion Based On RAND/UCLA …

2013

Abstract Introduction Cancer-related Venous Thromboembolism (VTE) requires treatment with Low Molecular Weight Heparin (LMWH), which is more effective and safer than warfarin; however, the risk of major hemorrhage still remains clinically relevant (up to 5%). This rate is even higher in case of impaired hemostasis, such as during thrombocytopenia (due to myelosuppression or chemo-therapy) where the bleeding risk is directly related to the platelet count level. At the present, the best management of adult patients with acute or non-acute cancer-related VTE during thrombocytopenia is uncertain. Objective To develop a consensus about the platelet cut-off for a safe LMWH administration in cance…

medicine.medical_specialtybusiness.industrymedicine.drug_classImmunologyAnticoagulantWarfarinLow molecular weight heparinCell BiologyHematologyHeparinCochrane Librarymedicine.diseaseBiochemistryThrombosisSurgeryClinical trialHemostasisInternal medicineMedicinebusinessmedicine.drugBlood
researchProduct

Dental management in patients with hemostasis alteration

2011

Haemostasis is a mechanism that, through different interdependent biologic processes, has the purpose of ensuring the integrity and permeability of the circulatory system. Hemostasis term means prevention the loss of blood. Interventions or treatments in the oral cavity, in particular those with a possibility of bleeding, represent a risk for patients with disorders of hemostasis. Prevention is the key to avoid bleeding complications after oral surgical procedures and therefore it is essential a detailed medical history of the patient. The appropriate diagnosis and treatment in patients with disorders of hemostasis, depends directly in the understanding of hemostasis standard mechanisms. Em…

medicine.medical_specialtybusiness.industrymedicine.drug_classMechanism (biology)AnticoagulantPsychological interventionOdontologíaOral Surgical Procedures:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgeryHemostasisUNESCO::CIENCIAS MÉDICASVon Willebrand diseaseMedicineMedical historyPlateletbusinessIntensive care medicineGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct